A detailed history of Tactive Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Tactive Advisors, LLC holds 3,233 shares of MRK stock, worth $322,879. This represents 0.23% of its overall portfolio holdings.

Number of Shares
3,233
Previous 2,455 31.69%
Holding current value
$322,879
Previous $268 Million 59.38%
% of portfolio
0.23%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 04, 2024

BUY
$113.24 - $131.95 $88,100 - $102,657
778 Added 31.69%
3,233 $427 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $245,941 - $267,644
2,455 New
2,455 $268 Million
Q3 2023

Feb 02, 2024

SELL
$102.95 - $114.33 $204,870 - $227,516
-1,990 Closed
0 $0
Q2 2023

Feb 02, 2024

BUY
$108.61 - $118.38 $216,133 - $235,576
1,990 New
1,990 $229,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Tactive Advisors, LLC Portfolio

Follow Tactive Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tactive Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tactive Advisors, LLC with notifications on news.